$18.66
-0.37-1.94%
最終更新: Nov 20, 8:54 AM

The average analyst price target for Claritev is $47, 151.9% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $30 to $86. The latest change came on Aug 21, 2026, when Barclays raised its price target on Claritev from $28 to $40 and kept an Overweight rating.
Price Target Range — 7 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months